| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2006;47:331.)
© 2006 American Heart Association, Inc.
Editorial Commentaries |
From the Departments of Medicine and Pharmacology and Center for Human Genetics and Genomics, University of California at San Diego, and VA San Diego Healthcare System, San Diego, California.
Correspondence to Daniel T. OConnor, MD, Department of Medicine and Pharmacology and Center for Human Genetics (0838), University of California at San Diego School of Medicine and VA San Diego Healthcare System, 9500 Gilman Dr, La Jolla, CA 92093. E-mail doconnor@ucsd.edu
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
| Introduction |
|---|
In the face of significant heritability yet uncertain mode of inheritance, a useful strategy may be to establish so-called "intermediate phenotypes" (Figure)3: ideally, simple Mendelian or monogenic traits that are associated with hypertension. The disorder may result from alterations in more than one gene, as well as different genes in subgroups of hypertensive subjects; hence, a particular intermediate phenotype may be present in all or only in a subgroup of essential hypertensives. Such a monogenic trait might be more directly determined by the action of a particular gene and, hence, subject to less environmental influence than a complex phenotype such as blood pressure. Thus, an intermediate phenotype might be helpful in identifying those offspring of essential hypertensives who have inherited susceptibility alleles predisposing them to later development of hypertension.
| |||||||||||
Evidence is accumulating for alteration of autonomic function in essential hypertension, especially activation of the sympathetic nervous system,3 which may be involved in not only the genesis of blood pressure elevation but also the progression of target-organ damage. Adrenergic regulation of blood pressure may be altered not only in hypertensives themselves, but also in their (normotensive) first-degree relatives (siblings and offspring): reported adrenergic disturbances in family members include diminished secretion
Related Article:
Hypertension 2006 47: 396-402.
This article has been cited by other articles:
![]() |
Y. Chen, F. Rao, J. L. Rodriguez-Flores, M. Mahata, M. M. Fung, M. Stridsberg, S. M. Vaingankar, G. Wen, R. M. Salem, M. Das, et al. Naturally Occurring Human Genetic Variation in the 3'-Untranslated Region of the Secretory Protein Chromogranin A Is Associated With Autonomic Blood Pressure Regulation and Hypertension in a Sex-Dependent Fashion J. Am. Coll. Cardiol., October 28, 2008; 52(18): 1468 - 1481. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. O'Connor, G. Zhu, F. Rao, L. Taupenot, M. M. Fung, M. Das, S. K. Mahata, M. Mahata, L. Wang, K. Zhang, et al. Heritability and Genome-Wide Linkage in US and Australian Twins Identify Novel Genomic Regions Controlling Chromogranin A: Implications for Secretion and Blood Pressure Circulation, July 15, 2008; 118(3): 247 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-a. B. Shih and D. T. O'Connor Hereditary Determinants of Human Hypertension: Strategies in the Setting of Genetic Complexity Hypertension, June 1, 2008; 51(6): 1456 - 1464. [Full Text] [PDF] |
||||
![]() |
F. Rao, L. Zhang, J. Wessel, K. Zhang, G. Wen, B. P. Kennedy, B. K. Rana, M. Das, J. L. Rodriguez-Flores, D. W. Smith, et al. Tyrosine Hydroxylase, the Rate-Limiting Enzyme in Catecholamine Biosynthesis: Discovery of Common Human Genetic Variants Governing Transcription, Autonomic Activity, and Blood Pressure In Vivo Circulation, August 28, 2007; 116(9): 993 - 1006. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |